Reduced risk for molecular disease in patients with chronic myeloid leukemia after transplantation from a KIR-mismatched donor

Ahmet H. Elmaagacli^*, Hellmut Ottinger, Michael Koldehoff, Rudolf Peceny, Nina K. Steckel, Rudolf Trenschel, Harald Biersack, Hans Grosse-Wilde, Dietrich W. Beelen

^*Corresponding author for this work